Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Cash (2016 - 2026)

Iradimed has reported Change in Cash over the past 14 years, most recently at $5.2 million for Q1 2026.

  • Quarterly Change in Cash rose 374.04% to $5.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Mar 2026, up 16.11% year-over-year, with the annual reading at -$1.1 million for FY2025, 143.49% down from the prior year.
  • Change in Cash was $5.2 million for Q1 2026 at Iradimed, up from -$5.4 million in the prior quarter.
  • Over five years, Change in Cash peaked at $5.2 million in Q1 2026 and troughed at -$15.2 million in Q1 2023.
  • The 5-year median for Change in Cash is $2.4 million (2022), against an average of -$330903.1.
  • Year-over-year, Change in Cash tumbled 1676.35% in 2022 and then skyrocketed 374.04% in 2026.
  • A 5-year view of Change in Cash shows it stood at $2.4 million in 2022, then rose by 27.37% to $3.0 million in 2023, then crashed by 82.99% to $513147.0 in 2024, then tumbled by 1145.95% to -$5.4 million in 2025, then skyrocketed by 197.16% to $5.2 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Change in Cash are $5.2 million (Q1 2026), -$5.4 million (Q4 2025), and $3.5 million (Q3 2025).